A drug with the SMILES Cc1ccc(C)c(-n2c(SCC(=O)N3CCC(C(=O)O)CC3)nnc2-c2cccc(Cl)c2)c1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 35.173%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1ccc(C)c(-n2c(SCC(=O)N3CCC(C(=O)O)CC3)nnc2-c2cccc(Cl)c2)c1
Cc1ccc(C)c(-n2c(SCC(=O)N3CCC(C(=O)O)CC3)nnc2-c2cccc(Cl)c2)c1
1-[2-[[5-(3-chlorophenyl)-4-(2,5-dimethylphenyl)-1,2,4-triazol-3-yl]sulfanyl]acetyl]piperidine-4-carboxylic acid